论文部分内容阅读
目的观察艾迪注射液治疗非小细胞肺癌所致胸腔积液的疗效及不良反应。方法 74例非小细胞肺癌并发胸腔积液的患者,留置中心静脉导管引流胸腔积液后,随机分为治疗组组和观察组,观察治疗胸腔积液的疗效及不良反应。结果治疗组组胸腔积液控制的有效率94.74%;观察组为75.00%。两组疗效差异有统计学意义(P<0.05),不良反应差异无统计学意义(P>0.05)。结论艾迪注射液治疗非小细胞肺癌所致胸腔积液的疗效明确,且不良反应少。
Objective To observe the curative effect and adverse reactions of Aidi injection in the treatment of pleural effusion caused by non-small cell lung cancer. Methods A total of 74 patients with non-small cell lung cancer complicated with pleural effusion were treated with indwelling central venous catheter drainage of pleural effusion and randomly divided into treatment group and observation group to observe the curative effect and adverse reactions of treatment of pleural effusion. Results The treatment group pleural effusion control efficiency of 94.74%; observation group was 75.00%. The difference between the two groups was statistically significant (P <0.05), the difference was not statistically significant (P> 0.05). Conclusion Aidi injection for the treatment of non-small cell lung cancer caused by pleural effusion clear effect, and less adverse reactions.